Definition:
Whole exome sequencing is a genomic technique that sequences all protein-coding regions (exons) of genes in a genome, known as the exome1. It captures approximately 1-2% of the human genome, containing about 85% of known disease-related variants.

Key Features:
- Sequences protein-coding regions of ~20,000 genes.
- Covers ~1-2% of the genome.
- More cost-effective than whole-genome sequencing.
- Typically requires 4-5 Gb of sequencing per exome.
Applications:
- Identifying disease-causing genetic variants.
- Cancer research and diagnostics.
- Rare disease diagnosis.
- Population genetics studies.
- Investigating alternative splicing events.
Advantages:
- Cost-effective compared to whole-genome sequencing.
- Focuses on regions most likely to affect phenotype.
- Can identify coding variants across various applications.
- Shorter turnaround time than whole-genome sequencing.
Limitations:
- Does not cover non-coding regions.
- May miss some disease-causing variants in introns.
- Limited ability to detect certain types of structural variants.
Process:
- DNA library preparation.
- Exome capture using probes.
- High-throughput sequencing.
- Data analysis and variant calling.
Clinical Relevance:
- Diagnostic tool for genetic disorders.
- Identification of pharmacologically druggable alterations.
- Detection of cancer-related genetic aberrations.
FAQs
- How does WES differ from whole-genome sequencing?
– WES focuses on protein-coding regions, while whole-genome sequencing covers the entire genome. - What is the diagnostic yield of WES?
– Studies have shown diagnostic yields ranging from 25-50% depending on the condition and patient population. - Can WES detect all types of genetic variants?
– WES is best at detecting single nucleotide variants and small insertions/deletions, but may miss some larger structural variants. - How long does WES analysis take?
– The sequencing process can be done in as little as 1 day, but full analysis and interpretation can take several weeks. - Is WES covered by insurance?
– Coverage varies by provider and indication. Many insurers now cover WES for specific clinical scenarios.

